Efficacy of Pancrelipase on Postprandial Belching and Bloating.

Completed · Phase 3

Conditions studied: Postprandial Bloating, Postprandial Belching, Postprandial Eructation

In brief

The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.

Key facts

Study ID

NCT00266721

Run by

Solvay Pharmaceuticals

People needed

45

Starts

2000-01-01

Expected to finish

2000-10-01

Last updated by the study team

2005-12-19

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects will have either bothersome upper abdominal discomfort, bloating (feeling of abdominal distention) or belching following meals for at least 12 month's duration. Subjects must have had a normal upper gastrointestinal endoscopy and/or upper GI series during the preceding three years.

You may not qualify if…

• Individuals with a history suggestive of organic disease such as recent weight loss, nausea, vomiting, GERD, recent changes in bowel habits will be excluded from the study.

Where it is running

• VAMC — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.